Clinical Trials Should Include Finding Maintenance Dose, FDA’s Temple Says
This article was originally published in The Pink Sheet Daily
Executive Summary
CDER medical policy director says more thorough dose-response work would help reduce drug failure rate, and commends J&J for its study of Risperdal dosing.